PB 108 of 2014
 
National Health Determination under paragraph 98C(1)(b) Amendment 2014
(No. 12)
_____________________________________________________________________
 
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.
 
Dated   17 December 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
1              Name of Instrument
(1)                This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2014 (No. 12).
(2)                This Instrument may also be cited as PB 108 of 2014.
2              Commencement                                                        
                This instrument commences on 1 January 2015.
3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)
                Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).
Schedule 1            Amendments
 
[1]        Schedule 4, after entry for Ethosuximide
insert:

Ezetimibe and rosuvastatin
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

 
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin
10 mg (as calcium)

 
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin
20 mg (as calcium)

 
Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin
40 mg (as calcium)